The present invention is directed to methods for treating Alzheimer's Disease by modulating divalent cation, trivalent cation and/or heparin interaction with amyloid precursor protein (APP). In particular, the present invention is directed to methods for treating Alzheimer's Disease by administering to a patient with Alzheimer's Disease a therapeutically effective amount of a zinc binding agent for modulating the interaction of zinc and/or heparin with APP and thereby preventing the aberrant processing of APP.
本发明涉及通过调节二价阳离子、三价阳离子和/或
肝素与淀粉样前体蛋白(APP)的相互作用来治疗阿尔茨海默病的方法。特别是,本发明涉及通过向阿尔茨海默病患者施用治疗有效量的
锌结合剂治疗阿尔茨海默病的方法,该
锌结合剂用于调节
锌和/或
肝素与APP的相互作用,从而防止APP的异常处理。